Ghost Tree Capital, LLC Fibrogen Inc Transaction History

Ghost Tree Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$2.49 - $20.59 $24,900 - $205,900	10,000 Added 37.74%	36,500 $98,000
Q1 2023 May 15, 2023	BUY	$15.95 - $25.18 $422,675 - $667,270	26,500 New	26,500 $494,000
Q2 2021 Aug 11, 2021	SELL	$18.57 - $35.68 $2.32 Million - $4.46 Million	-125,000 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$31.0 - $55.72 $3.88 Million - $6.97 Million	125,000 New	125,000 $4.34 Million
Q2 2019 Aug 14, 2019	SELL	$35.13 - $55.53 $403,995 - $638,595	-11,500 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$42.83 - $59.91 $492,545 - $688,965	11,500 New	11,500 $625,000

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.